Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.

MLA

Eric Bartee, et al. “Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease Following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells.” PLoS ONE, vol. 7, no. 8, Jan. 2012, p. e43298. EBSCOhost, https://doi.org/10.1371/journal.pone.0043298.

APA

Eric Bartee, Amy Meacham, Elizabeth Wise, Christopher R Cogle, & Grant McFadden. (2012). Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells. PLoS ONE, 7(8), e43298. https://doi.org/10.1371/journal.pone.0043298

Chicago

Eric Bartee, Amy Meacham, Elizabeth Wise, Christopher R Cogle, and Grant McFadden. 2012. “Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease Following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells.” PLoS ONE 7 (8): e43298. doi:10.1371/journal.pone.0043298.